Clinical Indication:

Non-alcoholic fatty liver disease (NAFLD)

Test Type:

Laboratory Developed Test (LDT)

Sample Type:

Plasma 

Number of Tests:

3

Modality:

Multi-RNA gene expression 

Assay Platform:

Real-time qPCR

Development Stage:

Clinical